Skip to main content

Descovy News (Page 2)

FDA Approves Descovy (emtricitabine and tenofovir alafenamide), Gilead’s Third TAF-Based HIV Therapy

FOSTER CITY, Calif., April 04, 2016 --(BUSINESS WIRE)--Gilead Sciences, Inc. (NASDAQ: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Descovy® (emtricitabine 200 ...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Pre-Exposure Prophylaxis, HIV Infection

Descovy patient information at Drugs.com